BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1708 related articles for article (PubMed ID: 18381893)

  • 1. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.
    Park SM; Gaur AB; Lengyel E; Peter ME
    Genes Dev; 2008 Apr; 22(7):894-907. PubMed ID: 18381893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2.
    Korpal M; Lee ES; Hu G; Kang Y
    J Biol Chem; 2008 May; 283(22):14910-4. PubMed ID: 18411277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.
    Gregory PA; Bert AG; Paterson EL; Barry SC; Tsykin A; Farshid G; Vadas MA; Khew-Goodall Y; Goodall GJ
    Nat Cell Biol; 2008 May; 10(5):593-601. PubMed ID: 18376396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma.
    Guo F; Cogdell D; Hu L; Yang D; Sood AK; Xue F; Zhang W
    Oncol Rep; 2014 May; 31(5):2021-8. PubMed ID: 24677166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.
    Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q
    Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma.
    Kurashige J; Kamohara H; Watanabe M; Hiyoshi Y; Iwatsuki M; Tanaka Y; Kinoshita K; Saito S; Baba Y; Baba H
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S656-64. PubMed ID: 22311119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma.
    Castilla MÁ; Moreno-Bueno G; Romero-Pérez L; Van De Vijver K; Biscuola M; López-García MÁ; Prat J; Matías-Guiu X; Cano A; Oliva E; Palacios J
    J Pathol; 2011 Jan; 223(1):72-80. PubMed ID: 21125666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition.
    Bendoraite A; Knouf EC; Garg KS; Parkin RK; Kroh EM; O'Briant KC; Ventura AP; Godwin AK; Karlan BY; Drescher CW; Urban N; Knudsen BS; Tewari M
    Gynecol Oncol; 2010 Jan; 116(1):117-25. PubMed ID: 19854497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targets of miR-200c mediate suppression of cell motility and anoikis resistance.
    Howe EN; Cochrane DR; Richer JK
    Breast Cancer Res; 2011 Apr; 13(2):R45. PubMed ID: 21501518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The p63 protein isoform ΔNp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205.
    Tran MN; Choi W; Wszolek MF; Navai N; Lee IL; Nitti G; Wen S; Flores ER; Siefker-Radtke A; Czerniak B; Dinney C; Barton M; McConkey DJ
    J Biol Chem; 2013 Feb; 288(5):3275-88. PubMed ID: 23239884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells.
    Tryndyak VP; Beland FA; Pogribny IP
    Int J Cancer; 2010 Jun; 126(11):2575-83. PubMed ID: 19839049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
    Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
    Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-200c modulates ovarian cancer cell metastasis potential by targeting zinc finger E-box-binding homeobox 2 (ZEB2) expression.
    Lu YM; Shang C; Ou YL; Yin D; Li YN; Li X; Wang N; Zhang SL
    Med Oncol; 2014 Aug; 31(8):134. PubMed ID: 25052237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of miR-200c/miR-141 in the regulation of epithelial-mesenchymal transition and migration in head and neck squamous cell carcinoma.
    Tamagawa S; Beder LB; Hotomi M; Gunduz M; Yata K; Grenman R; Yamanaka N
    Int J Mol Med; 2014 Apr; 33(4):879-86. PubMed ID: 24424572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 16. δEF1 associates with DNMT1 and maintains DNA methylation of the E-cadherin promoter in breast cancer cells.
    Fukagawa A; Ishii H; Miyazawa K; Saitoh M
    Cancer Med; 2015 Jan; 4(1):125-35. PubMed ID: 25315069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal-to-epithelial transition determinants as characteristics of ovarian carcinoma effusions.
    Elloul S; Vaksman O; Stavnes HT; Trope CG; Davidson B; Reich R
    Clin Exp Metastasis; 2010 Mar; 27(3):161-72. PubMed ID: 20213325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin.
    Hurteau GJ; Carlson JA; Spivack SD; Brock GJ
    Cancer Res; 2007 Sep; 67(17):7972-6. PubMed ID: 17804704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition.
    Zhang Z; Liu S; Shi R; Zhao G
    Cancer Genet; 2011 Sep; 204(9):486-91. PubMed ID: 22018270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A miRNA signature associated with human metastatic medullary thyroid carcinoma.
    Santarpia L; Calin GA; Adam L; Ye L; Fusco A; Giunti S; Thaller C; Paladini L; Zhang X; Jimenez C; Trimarchi F; El-Naggar AK; Gagel RF
    Endocr Relat Cancer; 2013 Dec; 20(6):809-23. PubMed ID: 24127332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 86.